American National Registered Investment Advisor’s Flexion Therapeutics, Inc. FLXN Stock Holding History

American National Registered Investment Advisor’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-47,550	Closed	-$290K	–	245
2021 Q3	$290K	Sell	47,550 -145	-0.3%	-$904	0.1%	212
2021 Q2	$393K	Sell	47,695 -375	-0.8%	-$3.19K	0.14%	184
2021 Q1	$430K	Sell	48,070 -25	-0.1%	-$287	0.17%	179
2020 Q4	$555K	Hold	48,095	–	–	0.22%	145
2020 Q3	$501K	Hold	48,095	–	–	0.23%	125
2020 Q2	$632K	Buy	+48,095	New	+$499K	0.31%	96

American National Registered Investment Advisor's FLXN Position: Q4 2021 in Review

American National Registered Investment Advisor sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 47,550 shares — an estimated $290K sold.

American National Registered Investment Advisor first reported a position in FLXN in Q2 2020 and held it in 6 quarters. The position peaked at $632K in Q2 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

American National Registered Investment Advisor reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
American National Registered Investment Advisor sold 47,550 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $290K.
American National Registered Investment Advisor first reported a position in Flexion Therapeutics, Inc. in Q2 2020 and held it in 6 quarters.
American National Registered Investment Advisor's Flexion Therapeutics, Inc. position peaked at $632K in Q2 2020.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on American National Registered Investment Advisor's 13F filing for Q4 2021, filed 9 Feb 2022.